Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS)
CNY 21.47
(6.93%)
CNY 21.47
(6.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.58 Billion | 1.55 Billion | 1.53 Billion | 1.31 Billion | 1.38 Billion | 1.32 Billion |
| Cost of Revenue | 491.37 Million | 503 Million | 466.98 Million | 441.48 Million | 448.71 Million | 442.29 Million |
| Gross Profit | 1.09 Billion | 1.05 Billion | 1.06 Billion | 877.4 Million | 938.06 Million | 878.22 Million |
| Operating Expenses | 953.58 Million | 882.01 Million | 876.98 Million | 754.92 Million | 738.19 Million | 767.61 Million |
| Selling, General and Administrative Expenses | 474.09 Million | 489.02 Million | 672.92 Million | 398.82 Million | 400.97 Million | 427.09 Million |
| Research and Development Expenses | 184.48 Million | 147.31 Million | 135.31 Million | 114.43 Million | 109.64 Million | 103.29 Million |
| Other Expenses | 24.77 Million | 245.68 Million | 68.74 Million | 241.66 Million | 227.57 Million | 2.38 Million |
| Cost and Expenses | 1.45 Billion | 1.38 Billion | 1.34 Billion | 1.19 Billion | 1.18 Billion | 1.2 Billion |
| Operating Income | 131.12 Million | 156 Million | 219.79 Million | 175.89 Million | 180.86 Million | 102.16 Million |
| Interest Expense | 10.93 Thousand | 1.26 Million | 1.64 Million | 3.76 Million | 10.89 Million | 10.62 Million |
| Income Tax Expense | 34.03 Million | 48.52 Million | 71.74 Million | 37.82 Million | 59.52 Million | 38.69 Million |
| Earnings before Tax | 132.58 Million | 155.2 Million | 222.95 Million | -89.09 Million | 113.47 Million | 104.54 Million |
| Net Income | 106.45 Million | 112.98 Million | 155.32 Million | -126.92 Million | 49.69 Million | 59.25 Million |
| Earnings Per Share Basic | 0.23 | 0.24 | 0.33 | -0.27 | 0.11 | 0.15 |
| Earnings Per Share Diluted | 0.23 | 0.24 | 0.33 | -0.27 | 0.11 | 0.15 |
| Weighted Average Shares Outstanding | 462.83 Million | 467.94 Million | 467.94 Million | 467.94 Million | 451.77 Million | 395.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 462.83 Million | 467.94 Million | 467.94 Million | 467.94 Million | 451.77 Million | 395.01 Million |
| Gross Margin | 0.69 | 0.68 | 0.70 | 0.67 | 0.68 | 0.67 |
| EBIT Margin | 0.17 | 0.20 | 0.27 | 0.21 | 0.20 | 0.36 |
| Profit Margin | 0.07 | 0.07 | 0.10 | -0.10 | 0.04 | 0.04 |
| EBITDA | 277.1 Million | 321.19 Million | 358.72 Million | 53.78 Million | 277.11 Million | 261.93 Million |
| Earnings Before Tax Margin | 0.08 | 0.10 | 0.14 | 0.13 | 0.13 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 403.61 Million | 404.3 Million | 393.09 Million | 387.36 Million | 1.58 Billion | 404.28 Million |
| Cost of Revenue | 115.71 Million | 125.03 Million | 123.18 Million | 125.03 Million | 491.37 Million | 117.2 Million |
| Gross Profit | 287.9 Million | 279.26 Million | 269.9 Million | 262.32 Million | 1.09 Billion | 287.08 Million |
| Operating Expenses | 222.81 Million | 221.38 Million | 216.73 Million | 260.36 Million | 918.35 Million | 222.89 Million |
| Selling, General and Administrative Expenses | 225.99 Million | 123.96 Million | 172.97 Million | -54.66 Million | - | 300.51 Million |
| Research and Development Expenses | 46.1 Million | 45.42 Million | 43.79 Million | 66.98 Million | - | 45.26 Million |
| Other Expenses | -49.27 Million | -3.31 Million | 31.32 Thousand | -36.05 Million | -34.62 Million | 1.81 Million |
| Cost and Expenses | 338.53 Million | 346.42 Million | 339.92 Million | 385.39 Million | 1.4 Billion | 340.1 Million |
| Operating Income | 62.35 Million | 57.91 Million | 53.17 Million | -41.16 Million | 131.12 Million | 63.5 Million |
| Interest Expense | 135.89 Thousand | 161.62 Thousand | 177.61 Thousand | 195.35 Thousand | 917.34 Thousand | 215.84 Thousand |
| Income Tax Expense | 16.02 Million | 12.83 Million | 15.25 Million | -10.31 Million | 34.03 Million | 16.73 Million |
| Earnings before Tax | 62.47 Million | 57.38 Million | 60.02 Million | -41.12 Million | 132.58 Million | 64.47 Million |
| Net Income | 48.32 Million | 45.03 Million | 40.14 Million | -26.05 Million | 106.45 Million | 49.83 Million |
| Earnings Per Share Basic | 0.11 | 0.09 | 0.09 | -0.06 | - | 0.11 |
| Earnings Per Share Diluted | 0.11 | 0.09 | 0.09 | -0.06 | - | 0.11 |
| Weighted Average Shares Outstanding | 455.89 Million | 455.89 Million | 446.1 Million | 467.94 Million | 462.83 Million | 467.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 455.89 Million | 500.39 Million | 446.1 Million | 467.94 Million | 462.83 Million | 467.94 Million |
| Gross Margin | 0.71 | 0.69 | 0.69 | 0.68 | 0.69 | 0.71 |
| EBIT Margin | 0.16 | 0.15 | 0.15 | -0.08 | - | 0.17 |
| Profit Margin | 0.12 | 0.11 | 0.10 | -0.07 | 0.07 | 0.12 |
| EBITDA | 62.61 Million | 62.26 Million | 59.19 Million | -30.05 Million | - | 69.64 Million |
| Earnings Before Tax Margin | 0.15 | 0.14 | 0.14 | -0.11 | 0.08 | 0.16 |
TRKNY
4772
7875
PBATF
6993
LEN